APC best practices presented at ketamine forum

APC CEO Scott Brunner and PCCA’s A.J. Day attended a forum in Washington, D.C., on the emergence of ketamine as an area of therapeutic interest, sponsored by the Reagan-Udall Foundation for the FDA. The best part: AJ was part of a panel discussion regarding APC’s ketamine compounding best practices document.